Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 259 Cyclophosphamide 244 Specimen Handling 197 fludarabine 175 Magnetic Resonance Spectroscopy 173 Biopsy 147 Nivolumab 122 Carboplatin 99 Radiotherapy 92 Paclitaxel 88 venetoclax 82 Cisplatin 82 fludarabine phosphate 79 Gemcitabine 79 Injections 69 Ipilimumab 64 Dexamethasone 62 atezolizumab 59 Cetuximab 58 Bevacizumab 58 Azacitidine 57 Radiation 56 Fluorouracil 56 durvalumab 54 Radiosurgery 53 Temozolomide 48 Rituximab 44 Oxaliplatin 44 Docetaxel 44 Irinotecan 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Ferrosoferric Oxide × 1 year × Clear all

NCT04900792 2025-12-03

XACT-Fe-GBM-01

University of Iowa

Phase 1 Active not recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡